Erwin Krediet is a PhD candidate at Leiden University Medical Center and psychologist/researcher at ARQ National Psychotrauma Centre. He also volunteers on the program team of ICPR.
CV
Erwin has been involved with the OPEN Foundation (who organizes ICPR) since 2010 as a board member and vice president since 2015.
He was a research associate for Eleusis (2016-2018), is presently an adherence rater / peer lead Europe for MAPS (since 2018) and a psychologist/researcher at ARQ National Psychotrauma Center.
Since 2019 he is also pursuing a PhD at the Leiden University that focuses on psychedelics (MDMA and ketamine in particular) for the treatment of PTSD.
Notable Research Papers
- Reviewing the Potential of Psychedelics for the Treatment of PTSD (Krediet et al., 2020)
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers (Family et al., 2020)
Find more on Google Scholar or PubMed
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)